kabutan

Oncolys BioPharma, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.

Fri Feb 7, 2025 3:00 pm JST Earnings

4588 Oncolys BioPharma Inc. 【J-GAAP】

Earnings Report

Oncolys BioPharma Inc. <4588> [TSE Growth] announced its financial results in the afternoon session on February 7th (15:00). The net loss (non-consolidated) for the fiscal year ending December 2024 was loss of 1.68 billion yen, a reduction in the deficit compared to loss of 1.68 billion yen in the previous term. This marks the thirteenth consecutive term of losses. Furthermore, the company did not disclose the performance outlook for the fiscal year ending December 2025.

In the most recent three-month period, from October to December (4Q), the net loss improved to a deficit of 0.43 billion yen (compared to a loss of 0.66 billion yen in the same period last year).

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 976 -1,204 -1,163 -1,148 -66.3 0 Feb 10, 2023 J-GAAP
Dec, 2023 63 -1,929 -1,913 -1,938 -108.9 0 Feb 9, 2024 J-GAAP
Dec, 2024 31 -1,681 -1,663 -1,684 -77.2 0 Feb 7, 2025 J-GAAP
YoY -50.8% +12.9% +13.1% +13.1% +29.1%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Guidance ー ー ー ー － 0 Feb 9, 2024 J-GAAP
Dec, 2024 Results 31 -1,681 -1,663 -1,684 -77.2 0 Feb 7, 2025 J-GAAP
Revision Rate － － － － －

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 31 -793 -752 -754 -37.0 0 Aug 9, 2024 J-GAAP
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 7, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 63 -1,929 -1,913 -1,938 -108.9 0 Feb 9, 2024 J-GAAP
Dec, 2024 31 -1,681 -1,663 -1,684 -77.2 0 Feb 7, 2025 J-GAAP
Dec, 2025 Guidance ー ー ー ー － 0 Feb 7, 2025 J-GAAP
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 0 -618 -643 -666 -37.4 -Inf Feb 9, 2024 J-GAAP
Jan - Mar, 2024 0 -378 -363 -364 -18.2 -Inf May 10, 2024 J-GAAP
Apr - Jun, 2024 31 -415 -389 -390 -19.1 -1,338.7 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 0 -437 -491 -492 -23.5 -Inf Nov 8, 2024 J-GAAP
Oct - Dec, 2024 0 -451 -420 -438 -20.1 -Inf Feb 7, 2025 J-GAAP
YoY － +27.0% +34.7% +34.2% +46.4%

Related Articles